Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-03-14
2010-06-22
Shiao, Rei-Tsang (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S397000, C548S335500
Reexamination Certificate
active
07741356
ABSTRACT:
The present invention is directed to novel opioid receptor modulators of Formula (I).The invention further relates to methods for preparing such compounds, pharmaceutical compositions containing them, and their use in the treatment of disorders that may be ameliorated or treated by the modulation of opioid receptors.
REFERENCES:
patent: 6013658 (2000-01-01), Lau et al.
patent: 1 055 665 (2000-11-01), None
patent: WO 96/22997 (1996-08-01), None
patent: WO 02/36116 (2002-05-01), None
patent: WO 03/033486 (2003-04-01), None
patent: WO 03/092688 (2003-11-01), None
Dufour E, et al; “Synthesis of amidrazones using an engineered papain nitrile hydratase”, Elsevier Science Publishers, Amsterdam, NL, vol. 433, No. 1-2, Aug. 14, 1998, pp. 78-82.
Hipskind P, et al “3-Aryl-1,2-diacetamidopropane Derivatives as Novel and Potent NK-1 Receptor Antagonists”, Belstein Institute For Organic Chemistry, Frankfurt-Main, DE; XP002330617, Database accession No. BRN: 7491912 abstract, J. Med. Chem., vol. 39, No. 3, 1996, pp. 736-748.
Tam J, et al, “Design and Synthesis of a Multi-Detachable Benzhydrylamine-Resin for Solid Phase Peptide Synthesis”, Frankfurt-Main, DE: XP002330618, Database accession No. BRN: 5166497 abstract, Tetrahedron Lett., , vol. 22, No. 30, 1981, pp. 2851-2854.
Santi, D, “Tyrosyl Transfer Ribonucleic Acid Synthetase fromEscherichia coliB. Analysis of Tyrosine and Adenosine 5-Triphospate Binding Sites”, Belstein Institute For Organic Chemistry,, Frankfurt-Main, DE; XP002330619, Database accession No. BRN: 7278453 abstract, J. Med. Chem., vol. 16, No. 3, 1973, pp. 273-280.
Search report for International Appl. No. PCT/US2005/008339.
Breslin Henry J.
Cai Chaozhong
He Wei
Kavash Robert W.
Janssen Pharmaceutica N.V.
Kosack Joseph R
Shiao Rei-Tsang
LandOfFree
Compounds as opioid receptor modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds as opioid receptor modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds as opioid receptor modulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4244557